Kbc Group Nv Embecta Corp. Transaction History

Kbc Group Nv

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.87 - $19.09 $35,585 - $52,783	-2,765 Reduced 61.28%	1,747 $33,000
Q3 2023 Feb 15, 2024	SELL	$15.0 - $22.17 $35,445 - $52,387	-2,363 Reduced 52.37%	2,149 $32,000
Q2 2023 Feb 15, 2024	SELL	$21.6 - $30.69 $62,596 - $88,939	-2,898 Reduced 39.11%	4,512 $97,000
Q2 2023 Jul 28, 2023	SELL	$21.6 - $30.69 $11,080 - $15,743	-513 Reduced 10.21%	4,512 $97,000
Q1 2023 Feb 14, 2024	SELL	$23.07 - $32.77 $3,875 - $5,505	-168 Reduced 3.24%	5,025 $141,000
Q1 2023 May 04, 2023	SELL	$23.07 - $32.77 $55,021 - $78,156	-2,385 Reduced 32.19%	5,025 $141,000
Q4 2022 Feb 14, 2024	SELL	$25.29 - $35.48 $112,591 - $157,956	-4,452 Reduced 46.16%	5,193 $131,000
Q3 2022 Feb 15, 2024	BUY	$24.0 - $33.42 $135,912 - $189,257	5,663 Added 324.16%	7,410 $213,000
Q3 2022 Nov 08, 2022	SELL	$24.0 - $33.42 $53,640 - $74,693	-2,235 Reduced 23.17%	7,410 $213,000
Q2 2022 Feb 14, 2024	BUY	$24.78 - $33.36 $195,712 - $263,477	7,898 Added 452.09%	9,645 $244,000
Q2 2022 Jul 26, 2022	BUY	$24.78 - $33.36 $239,003 - $321,757	9,645 New	9,645 $244,000

403

51.2M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $846M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.